WHO chief praises Guineans for help with Ebola vaccine

May 4, 2017

The head of the World Health Organization is praising Guineans for their role in helping to develop a vaccine against the deadly Ebola virus.

On a visit to the country where the world's deadliest Ebola outbreak emerged in 2013, Dr. Margaret Chan said Guineans had "fought back" by helping scientists.

There is no licensed treatment for Ebola, and the outbreak killed more than 11,300 people. Researchers began testing the vaccine as the outbreak was waning.

WHO, which has acknowledged shortcomings in its response to the Ebola outbreak in West Africa, led the study of the vaccine.

The vaccine was developed by the Canadian government and is now licensed to the U.S.-based Merck & Co.

Chan says the 's impact will be significant even if supplies initially are limited.

Explore further: Ebola vaccine shows 'promising' results: WHO

Related Stories

Ebola vaccine shows 'promising' results: WHO

July 31, 2015
Preliminary results of tests on an Ebola vaccine to be published later Friday in British science magazine The Lancet have shown "promising" results, World Health Organization Director-General Margaret Chan said.

Johnson & Johnson starts Ebola vaccine trial in Sierra Leone

October 9, 2015
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.

Russia says its Ebola vaccine 'effective' in initial tests

February 15, 2016
Russia's health minister said Monday that an Ebola vaccine developed by the country over the last 15 months had shown encouraging results and would undergo further testing in West Africa.

Global Vaccine promises $5 million to develop Ebola vaccine

January 20, 2016
The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017.

Ebola vaccine trial begins in Sierra Leone

April 14, 2015
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.

WHO yet to take Canada's experimental Ebola vaccine

October 9, 2014
Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.